ESPR
NASDAQ · Pharmaceuticals
Esperion Therapeutics Inc
$3.18
-0.01 (-0.31%)
Open$3.18
Previous Close$3.19
Day High$3.19
Day Low$3.18
52W High$4.18
52W Low$1.38
Volume—
Avg Volume21.88M
Market Cap819.46M
P/E Ratio—
EPS$-0.06
SectorPharmaceuticals
Analyst Ratings
Sell
11 analysts
Price Target
+494.7% upside
Current
$3.18
$3.18
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 499.77M | 285.94M | 122.60M |
| Net Income | -28,114,344 | -14,477,005 | 36.77M |
| Profit Margin | -5.6% | -5.4% | 30.0% |
| EBITDA | 74.86M | 40.69M | 61.92M |
| Free Cash Flow | — | — | 30.39M |
| Rev Growth | +74.8% | +74.8% | -8.9% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |